--- title: CDMOs offering Secondary Packaging & Labeling with Small Molecule path: /explore/secondary-packaging/small-molecule companies_count: 25 --- # CDMOs offering Secondary Packaging & Labeling with Small Molecule 25 published CDMOs match Secondary Packaging & Labeling and Small Molecule. Locations in this set include United States, United Kingdom, Canada, Japan, China, and France. Capabilities that show up most often in this set: Quality Control Testing, Formulation Development, CMC Analytical Development, Process Development, and Sterile Fill-Finish & Aseptic Manufacturing. ## Matching companies - [Adragos Pharma](/companies/adragos-pharma) - Global CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan. - [Aenova Group](/companies/aenova-group) - Aenova Group is a worldwide leading contract manufacturer for the pharmaceutical and healthcare industry, offering solid dosage, sterile, semi-solid, and softgel manufacturing across multiple European and North American facilities. - [Almac Group](/companies/almacgroup) - Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities. - [Bend Bioscience](/companies/bend-bioscience) - U.S. pharmaceutical CDMO offering design, development, and manufacturing of oral solid and liquid dosage forms, from early formulation to commercial-scale production across three domestic locations. - [Burrard Pharmaceuticals](/companies/burrardpharma) - Vancouver-based CDMO delivering technology transfer, formulation development, and GMP manufacturing for 75+ molecules across oncology, diabetes, and respiratory therapeutics since 2005. - [Bushu Pharmaceuticals](/companies/bushu-pharma) - Bushu Pharmaceuticals is a contract development and manufacturing organization (CDMO) specializing in pharmaceutical contract manufacturing with over 25 years of experience. - [Catalent](/companies/catalent) - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply. - [Codis](/companies/codis) - Global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and continuous granulation with 400,000 sq ft of GMP manufacturing across US and UK facilities. - [Confab](/companies/confab) - Confab is a recognized CDMO offering contract manufacturing, formulation development, technology transfer, and analytical services for prescription, over-the-counter, generic, controlled, and veterinary pharmaceuticals across liquid, solid, and semi-solid dosage forms. - [CordenPharma](/companies/cordenpharma) - Full-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees. - [Delpharm](/companies/delpharm) - Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually. - [Grand River Aseptic Manufacturing](/companies/grandriverasepticmfg) - Sterile injectable CDMO specializing in fill-finish services for liquid and lyophilized vials, syringes, and cartridges, with Annex 1 compliant facilities and experience in biologics, small molecules, and vaccines. - [IDT Australia](/companies/idtaus-com) - IDT Australia is a cGMP CDMO delivering end-to-end pharmaceutical development and manufacturing services from active pharmaceutical ingredients to finished dosage forms, with expertise in small molecule APIs, specialty orals, advanced therapies, and integrated regulatory support. - [Lifecore](/companies/lifecore) - Lifecore is a sterile injectable CDMO with 60 years of regulatory experience, offering end-to-end services including formulation and process development, aseptic manufacturing, fill-finish, analytical testing, stability, and assembly and packaging for drugs, biologics, medical devices, and combination products. - [Medicap Laboratories](/companies/medicaplab) - Canadian CDMO for advanced oral drug delivery, offering contract manufacturing, pharmaceutical packaging, analytical testing and product development. Proprietary Hypermatrix, PODRAS and nPODDDS platforms target controlled-release and abuse-deterrent products. - [Medpharm](/companies/medpharm) - Specialized CDMO for topical, transdermal, and transepithelial drug products offering formulation development, analytical testing, process scale-up, and GMP manufacturing from early development through commercialization. - [PCI Pharma Services](/companies/pci) - Global CDMO with 8,000+ employees across 38 GMP facilities offering sterile and non-sterile development, manufacturing, fill-finish, lyophilization, prefilled syringes, drug-device combinations, cold chain packaging, and clinical trial services. - [Patheon (Thermo Fisher Pharma Services)](/companies/patheon) - Patheon is a trusted global contract development and manufacturing organization (CDMO) partner owned by Thermo Fisher Scientific, offering 360° integrated solutions from early-stage R&D through clinical supply and commercial manufacturing. - [Pharmaceutics International, Inc.](/companies/pharm-int) - Drug product CDMO specializing in aseptic injectables, oral solid dose, lyophilization, and prefilled syringes with 30+ years of experience in complex formulations and potent compounds; now part of Jabil. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.